Industry Show Ima Active Sponsors Event for Pharma Experts

Source: Press release Ahlam Rais 3 min Reading Time

Related Vendors

Ima Active was the sole sponsor of ‘ISPE Summer Night’, an event which brings together pharmaceutical professionals, academics and regulatory experts under one roof. At the show, all the guests shared their experiences and had lively discussions.

The 2023 edition of the event, which took place on 28 June, was dedicated to digitization and automation in the pharmaceutical sector.(Source:  Marco Muscas/Ima Active)
The 2023 edition of the event, which took place on 28 June, was dedicated to digitization and automation in the pharmaceutical sector.
(Source: Marco Muscas/Ima Active)

Bologna/Italy – This year Ima Active is the sole sponsor of the traditional summer event ‘ISPE Summer Night’ which brings together pharmaceutical professionals, academics and regulatory experts to share experiences, case studies and participate in interactive discussions.

The 2023 edition of the event, which took place on 28 June at the Mudec – Museum of Cultures of Milan, was dedicated to digitization and automation in the pharmaceutical sector: a global priority to innovate and modernize the production and logistics processes of this ever-evolving and rapidly innovating sector.

ISPE Summer Night was an opportunity to promote the change of paradigm in drug production. The industries of the sector must increasingly remain competitive on the global market, guaranteeing the availability, efficacy and safety of the products.

Innovation in new ‘smart’ ways can bring reliability, quality, competitiveness and sustainability to the pharmaceutical industry.

It must not be forgotten that consumers in the pharmaceutical sector are patients, who use the products for their well-being and health and that the pharmaceutical sector, in addition to the challenges of each industrial sector, is called upon to ensure ever greater availability, efficacy and safety.

Stay up to Date

Do you want the latest news, specialist articles and information on new products? Then you can register for our free newsletter:

Choose your Newsletter

To overcome the challenges that await us, it is necessary to implement faster innovation, with different methods and with broader objectives, compared with what has happened up to now. New ‘smart’ modes are available today, which allow greater operational flexibility and full modularity in the machine integration, processes, digital solutions and especially people. We get there with new and multidisciplinary perspectives that allow us to design, develop and implement - in full harmony - new production systems that bring reliability, quality, competitiveness and sustainability to our industry.

An unmissable appointment to reflect on these issues, using the fascinating metaphor of conducting an orchestra.

The metaphor of the orchestra and its conductor is proposed to compare two apparently different spheres: the pharmaceutical production and music. Just as the mechanisms that support the work of an orchestra take into account the personal dynamics that develop internally to obtain a harmonious result, in the same way the production of a tablet needs that each part of the process performs with the best quality and coordinates with the entire production strategy.

Just as in music it is necessary for the conductor to orchestrate all the excellent instrumentalists in harmony, similarly in the production of drugs an integrated control system that orchestrates all the production units in synergy is certainly advantageous. The aim is to guarantee systematic control of critical parameters and, ultimately, to ensure the final quality of the product, i.e. the safety of the drug which is, in reality, its primary goal.

Master, the integrated control system designed by Ima Active and used to manage an entire continuous production line as if it were a single unit, was presented during the event. Its modular design allows for easy integration of different units and draws the operator's attention to only the key production parameters.

(ID:49600871)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent